The goal of our research is to provide doctors with key, additional information to choose best treatment strategies for breast cancers with novel mutations of unknown significance. (vicc.org)
One test has evaluated women with atypical - squamous cells of unknown significance in which there is no therapy or medical evidence available. (ellagic.net)
Former Meilerlab graduate student Gregory Sliwoski won best presentation price at the Department of Biomedical Informatics research forum «A clinic - driven pipeline for prioritizing variants of unknown significance with personalized structural biology». (meilerlab.org)